CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,504 | +39.1% | 2,400 | +118.2% | 0.00% | – |
Q2 2023 | $2,519 | +151.6% | 1,100 | 0.0% | 0.00% | – |
Q1 2023 | $1,001 | – | 1,100 | +1000.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 100 | -90.9% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -33.3% | 1,100 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | -40.0% | 1,100 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | +66.7% | 1,100 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | -25.0% | 1,100 | +10.0% | 0.00% | – |
Q4 2020 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
COWEN INC. | 588,706 | $5,051,000 | 0.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
Hikari Power Ltd | 32,090 | $275,000 | 0.03% |